Myelodysplastic Syndrome

News

ATLG fights GVHD but reduces PFS, OS

Results of a phase 3 trial suggest rabbit anti-T lymphocyte globulin (ATLG) can reduce graft-versus-host disease (GVHD) but also decrease survival...

Pages